← Leaderboards
Joshua A Kritzer
Tufts University Medford
$8,375,849
Attributed
$8,375,849
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,375,849 · 7
By mechanism
R01$3,589,876 · 3
DP2$2,302,500 · 1
R35$1,989,692 · 1
R21$348,581 · 1
F32$145,200 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsCellsDesignMediatingCellular BiologyBaseLibrariesPenetrationAreaInnovationEndosomesStructureBiologyReportingCell TypeKineticsDrug DevelopmentCytosolPeptidesMalignant NeoplasmsDrug DiscoveryInhibitor/AntagonistPharmaceutical PreparationsGenetic
Grant awards (25)
Developing Autophagy-Targeting Chimeras and Optimizing Cell Penetration of Large-Molecule Therapeutics$577,898
R35 · FY2025 · GM · contact PI
Developing Autophagy-Targeting Chimeras and Optimizing Cell Penetration of Large-Molecule Therapeutics$633,124
R35 · FY2024 · GM · contact PI
Developing Autophagy-Targeting Chimeras and Optimizing Cell Penetration of Large-Molecule Therapeutics$129,450
R35 · FY2024 · GM · contact PI
Diversity Supplement for Imani McDonald - Developing Autophagy-Targeting Chimeras and Optimizing Cell Penetration of Large-Molecule Therapeutics$70,196
R35 · FY2024 · GM · contact PI
Developing Autophagy-Targeting Chimeras and Optimizing Cell Penetration of Large-Molecule Therapeutics$579,024
R35 · FY2023 · GM · contact PI
Cell Penetration Profiling for Biotherapeutics$360,446
R01 · FY2022 · GM · contact PI
Translation of Hot Loops into Macrocyclic Inhibitors of Protein-Protein Interactions$287,594
R01 · FY2021 · GM · contact PI
Cell Penetration Profiling for Biotherapeutics$285,398
R01 · FY2021 · GM · contact PI
Translation of Hot Loops into Macrocyclic Inhibitors of Protein-Protein Interactions$288,673
R01 · FY2020 · GM · contact PI
Cell Penetration Profiling for Biotherapeutics$285,821
R01 · FY2020 · GM · contact PI
Cell Penetration Profiling for Biotherapeutics$38,000
R01 · FY2020 · GM · contact PI
Cell Penetration Profiling for Biotherapeutics$286,228
R01 · FY2019 · GM · contact PI
Translation of Hot Loops into Macrocyclic Inhibitors of Protein-Protein Interactions$274,448
R01 · FY2019 · GM · contact PI
Cell Penetration Profiling for Biotherapeutics$87,299
R01 · FY2019 · GM · contact PI
Translation of Hot Loops into Macrocyclic Inhibitors of Protein-Protein Interactions$277,944
R01 · FY2018 · GM · contact PI
Cell Penetration Profiling for Biotherapeutics$261,561
R01 · FY2018 · GM · contact PI
High-Throughput Assays for Inhibitors of Understudied Bacterial Proteases$292,643
R01 · FY2017 · GM · contact PI
High-Throughput Assays for Inhibitors of Understudied Bacterial Proteases$284,242
R01 · FY2016 · GM · contact PI
High-Throughput Assays for Inhibitors of Understudied Bacterial Proteases$279,579
R01 · FY2015 · GM · contact PI
Rapid Generation of Isoform-Selective Histone Deacetylase Inhibitors$163,181
R21 · FY2012 · AG · contact PI
Rapid Generation of Isoform-Selective Histone Deacetylase Inhibitors$185,400
R21 · FY2011 · AG · contact PI
Drugging the Undruggable: Targeting Transcription Factors with Small Cyclic Pept$2,302,500
DP2 · FY2010 · OD · contact PI
Mechanism of Amyloid Inhibition by Small Molecules$50,428
F32 · FY2008 · NS · contact PI
Mechanism of Amyloid Inhibition by Small Molecules$48,796
F32 · FY2007 · NS · contact PI
Mechanism of Amyloid Inhibition by Small Molecules$45,976
F32 · FY2006 · NS · contact PI